A Phase 4 Study to Assess Symptoms of Exocrine Pancreatic Insufficiency in Subjects with Cystic Fibrosis or Chronic Pancreatitis Treated with Creon (Pancrelipase) with an Alternate Source of Active Pharmaceutical Ingredient

Brief description of study

The goal of this study is to be able to determine the effects taking CREON for patients suffering from exocrine pancreatic insufficiency (EPI) due to Chronic pancreatitis (CP) or Cystic Fibrosis (CF). This study will last about 5 months and will involve 2-3 in person visits. Participants will be asked to provide information regarding their demographic, and medical history. As well as complete 1 blood draw, and fill out surveys related to their overall health. Participants must have a medical condition (Exocrine Pancreatic Insufficiency) being studied and/or are scheduled to have test/procedure.

Clinical Study Identifier: s21-01159
Principal Investigator: Tamas A Gonda.
Other Investigator: Lauren G. Khanna.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.